Short answer
Approximate detection windows.
These ranges are not as standardized as they are for common workplace drug-test substances. Detection depends on dose, frequency, product strength, metabolism, liver function, body composition, hydration, and the laboratory method.
The most defensible statement is this: standard drug screens generally do not include kratom unless mitragynine or related alkaloids are specifically ordered.
Effects vs. detection
How long do kratom’s effects last?
The felt effect and the detection window are different.
Many people feel kratom within 10 to 30 minutes after taking it orally. Effects often peak around 1 to 2 hours. The total felt effect commonly lasts about 2 to 6 hours, depending on dose and product.
Concentrated 7-OH products may feel different from kratom leaf. They may feel more clearly opioid-like, and some users report a stronger cycle of relief, withdrawal, and redosing.
A drug test detects molecules or metabolites. You can stop feeling kratom and still have a positive kratom-specific test later.
What gets tested
What is usually measured?
Most kratom-specific urine tests look for mitragynine, the most abundant kratom alkaloid.
Some tests also look for 7-hydroxymitragynine, often called 7-OH. But interpretation can be difficult. 7-OH can be present in trace amounts in natural kratom leaf, can be formed when mitragynine is metabolized, and can also be present at enhanced levels in concentrated products.
A positive mitragynine test usually means recent kratom exposure. It does not reliably tell you:
- The dose.
- The route.
- Whether the product was leaf, extract, or concentrated 7-OH.
- Whether the person is intoxicated at the time of testing.
- Whether the person has kratom use disorder.
Testing is one piece of information. Product details and self-report often matter more clinically.
Standard drug tests
Does kratom show up on a standard drug test?
Usually, no.
Standard 5-panel and many 10-panel drug screens generally do not test for kratom alkaloids. They are usually designed to detect substances such as cannabinoids, cocaine, amphetamines, PCP, and certain opioids. Expanded panels may include benzodiazepines, methadone, oxycodone, barbiturates, or other medications, depending on the setting.
Kratom alkaloids are not the same as morphine, codeine, oxycodone, fentanyl, or buprenorphine. A routine opioid immunoassay should not be assumed to detect kratom.
However, kratom-specific testing exists. Some laboratories offer urine testing for mitragynine and 7-OH using mass spectrometry. A court, treatment program, employer, clinician, or forensic setting can order a kratom-specific test if that is part of the panel.
Practical implications:
- A standard drug screen does not prove someone is not using kratom.
- A kratom-specific positive result usually indicates recent exposure.
- A mitragynine result does not automatically distinguish leaf from extract or 7-OH product use.
- A negative routine screen may simply mean kratom was not tested.
What affects detection
Factors that affect how long kratom stays in the body.
Several factors influence detection:
Dose: Higher doses usually increase detection likelihood and duration.
Frequency: Daily or multiple-times-daily use can extend detection.
Product type: Extracts and concentrated products may deliver higher alkaloid exposure than leaf.
Liver function: Kratom alkaloids are metabolized in the liver, so liver impairment may affect clearance.
Body composition: Mitragynine is lipophilic, which may contribute to variability.
Metabolism and age: Slower metabolism may extend detection.
Laboratory method: Mass spectrometry is more specific than routine immunoassay screening.
Hydration: Hydration can affect urine concentration, but it does not reliably clear kratom from the body faster.
There is no reliable way to “flush” kratom out with water, exercise, saunas, or commercial “detox” products. Time and metabolism are the main factors.
In treatment
What this means in treatment.
For patients in addiction treatment, a few points matter:
- Routine urine drug testing may not include kratom.
- A clinician may need to order mitragynine or kratom-specific testing if it is clinically important.
- Self-report is often more helpful than testing alone.
- Product photographs can be useful, especially if 7-OH products or extracts are involved.
- A positive kratom test should start a clinical conversation, not automatically trigger punishment.
If you are using kratom while on buprenorphine or other treatment, tell your prescriber directly. The goal should be safety, not surprise testing.
Treatment
Treatment for kratom and 7-OH dependence is available online.
If you are concerned about kratom use for yourself or someone you care about, MyStreetHealth offers physician-led telehealth treatment in Virginia, West Virginia, Maryland, Washington DC, and Ohio. Same-day visits are often available when the schedule permits. No insurance is required.
Medical note
Kratom and 7-OH products vary widely in strength, purity, labeling accuracy, and legal status. This page is educational and does not replace medical care. Seek urgent medical advice for jaundice, severe vomiting or dehydration, chest pain, confusion, fainting, seizure, severe sedation, slowed breathing, pregnancy, or use with alcohol, benzodiazepines, opioids, gabapentin, pregabalin, or other sedatives.